Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-7 ERVK-18 ERVK-25 BACE2 ERVK-8	2.84e-06	37	219	6	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-7 ERVK-18 ERVK-25 BACE2 ERVK-8	3.35e-06	38	219	6	GO:0070001
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-11 ERVK-8	4.37e-06	11	219	4	GO:0004523
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-7 ERVK-11 ERVK-8	1.29e-05	14	219	4	GO:0003964
GeneOntologyMolecularFunction	DNA polymerase activity	ERVK-6 ERVK-7 ERVK-11 REV3L ERVK-8	5.67e-05	38	219	5	GO:0034061
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-7 ERVK-11 ERVK-8	7.28e-05	21	219	4	GO:0035613
GeneOntologyMolecularFunction	RNA endonuclease activity, producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-11 ERVK-8	7.00e-04	37	219	4	GO:0016891
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	MTA2 MEF2D KAT8 TAF1 DCAF13 PRAMEF17 PPID YWHAH ZFPM2 CDK5RAP3 MTA1 ARRB1 PROX1	7.33e-04	417	219	13	GO:0061629
GeneOntologyMolecularFunction	RNA nuclease activity	ERVK-6 DIS3L ERVK-7 ERVK-11 DIS3 ERVK-8 SLFN11	7.66e-04	136	219	7	GO:0004540
GeneOntologyBiologicalProcess	DNA integration	ERVK-6 ERVK-7 ERVK-11 ERVK-8	7.91e-06	13	217	4	GO:0015074
Domain	ELM2_dom	MTA2 MTA3 MIER1 MTA1	1.03e-05	13	210	4	IPR000949
Domain	ELM2	MTA2 MTA3 MIER1 MTA1	1.03e-05	13	210	4	PF01448
Domain	ELM2	MTA2 MTA3 MIER1 MTA1	1.03e-05	13	210	4	PS51156
Domain	ELM2	MTA2 MTA3 MIER1 MTA1	1.03e-05	13	210	4	SM01189
Domain	-	ATR TRRAP PIK3C2A PI4KA	2.54e-05	16	210	4	1.10.1070.11
Domain	PI3Kc	ATR TRRAP PIK3C2A PI4KA	2.54e-05	16	210	4	SM00146
Domain	PI3_PI4_kinase	ATR TRRAP PIK3C2A PI4KA	4.20e-05	18	210	4	PF00454
Domain	PI3_4_KINASE_1	ATR TRRAP PIK3C2A PI4KA	4.20e-05	18	210	4	PS00915
Domain	PI3_4_KINASE_2	ATR TRRAP PIK3C2A PI4KA	4.20e-05	18	210	4	PS00916
Domain	PI3/4_kinase_cat_dom	ATR TRRAP PIK3C2A PI4KA	4.20e-05	18	210	4	IPR000403
Domain	PI3_4_KINASE_3	ATR TRRAP PIK3C2A PI4KA	4.20e-05	18	210	4	PS50290
Domain	Rrp44_S1	DIS3L DIS3	1.26e-04	2	210	2	PF17215
Domain	RRP44_S1	DIS3L DIS3	1.26e-04	2	210	2	IPR033770
Domain	ARM-type_fold	PDS5B ATR DOCK11 APC2 TRRAP NCAPG2 PIK3R4 PIK3C2A RPTOR PI4KA UTP20 AGBL1 ZBTB7C	1.27e-04	339	210	13	IPR016024
Domain	SANT_dom	MTA2 MTA3 MIER1 MTA1	1.91e-04	26	210	4	IPR017884
Domain	HEAT	ATR NCAPG2 PIK3R4 RPTOR UTP20	1.98e-04	48	210	5	PF02985
Domain	BAH	MTA2 MTA3 MTA1	2.16e-04	11	210	3	PS51038
Domain	BAH_dom	MTA2 MTA3 MTA1	2.16e-04	11	210	3	IPR001025
Domain	BAH	MTA2 MTA3 MTA1	2.16e-04	11	210	3	SM00439
Domain	BAH	MTA2 MTA3 MTA1	2.16e-04	11	210	3	PF01426
Domain	SANT	MTA2 MTA3 MIER1 MTA1	2.57e-04	28	210	4	PS51293
Domain	7TM_GPCR_Srsx	OR2M2 OR2M3 OR2T34 OR2T3 OR56B1 CNR1 HTR1B	2.75e-04	112	210	7	SM01381
Domain	ZnF_GATA	MTA2 MTA3 MTA1	2.86e-04	12	210	3	SM00401
Domain	RIBONUCLEASE_II	DIS3L DIS3	3.75e-04	3	210	2	PS01175
Domain	Rrp44_CSD1	DIS3L DIS3	3.75e-04	3	210	2	PF17216
Domain	Rrp44_CSD1	DIS3L DIS3	3.75e-04	3	210	2	IPR033771
Domain	HEAT	ATR NCAPG2 PIK3R4 RPTOR UTP20	4.84e-04	58	210	5	IPR000357
Domain	Olfact_rcpt	OR8H3 OR2M7 OR2M2 OR2M5 OR2M3 OR2T34 OR2T3 OR56B1 OR2AT4 OR4C6 OR10R2 OR10Z1 OR4C12	5.28e-04	393	210	13	IPR000725
Domain	PI3/4_kinase_CS	ATR PIK3C2A PI4KA	5.77e-04	15	210	3	IPR018936
Domain	Znf_GATA	MTA2 MTA3 MTA1	5.77e-04	15	210	3	IPR000679
Domain	GATA	MTA2 MTA3 MTA1	5.77e-04	15	210	3	PF00320
Domain	Myb_DNA-binding	MTA2 MTA3 MIER1 MTA1	6.19e-04	35	210	4	PF00249
Domain	GATA_ZN_FINGER_1	MTA2 MTA3 MTA1	7.04e-04	16	210	3	PS00344
Domain	GATA_ZN_FINGER_2	MTA2 MTA3 MTA1	7.04e-04	16	210	3	PS50114
Domain	Nebulin	NEB NRAP	7.44e-04	4	210	2	PF00880
Domain	RNase_II/R_CS	DIS3L DIS3	7.44e-04	4	210	2	IPR022966
Domain	NEBULIN	NEB NRAP	7.44e-04	4	210	2	PS51216
Domain	NEBU	NEB NRAP	7.44e-04	4	210	2	SM00227
Domain	Nebulin	NEB NRAP	7.44e-04	4	210	2	IPR013998
Domain	Nebulin_repeat	NEB NRAP	7.44e-04	4	210	2	IPR000900
Domain	MYB_LIKE	MTA2 MTA3 MIER1 MTA1	8.50e-04	38	210	4	PS50090
Domain	Kinesin_motor_CS	KIF2C KIF6 KIF3A KIF13A	1.14e-03	41	210	4	IPR019821
Domain	HEAT_REPEAT	PDS5B ATR NCAPG2 PIK3R4 UTP20	1.15e-03	70	210	5	PS50077
Domain	FN3	LRIT3 USH2A COL12A1 FN1 KALRN TNC LIFR LRRN3	1.19e-03	185	210	8	SM00060
Domain	Kinesin-like_fam	KIF2C KIF6 KIF3A KIF13A	1.36e-03	43	210	4	IPR027640
Domain	-	KIF2C KIF6 KIF3A KIF13A	1.48e-03	44	210	4	3.40.850.10
Domain	Kinesin	KIF2C KIF6 KIF3A KIF13A	1.48e-03	44	210	4	PF00225
Domain	KISc	KIF2C KIF6 KIF3A KIF13A	1.48e-03	44	210	4	SM00129
Domain	KINESIN_MOTOR_1	KIF2C KIF6 KIF3A KIF13A	1.48e-03	44	210	4	PS00411
Domain	Kinesin_motor_dom	KIF2C KIF6 KIF3A KIF13A	1.48e-03	44	210	4	IPR001752
Domain	KINESIN_MOTOR_2	KIF2C KIF6 KIF3A KIF13A	1.48e-03	44	210	4	PS50067
Domain	GPCR_Rhodpsn_7TM	OR8H3 OR2M7 OR2M2 OR2M5 OR2M3 OR2T34 OR2T3 OR56B1 OR2AT4 CNR1 HTR1B GPR22 GPER1 OR4C6 OR10R2 OR10Z1 OR4C12	1.55e-03	670	210	17	IPR017452
Domain	7tm_1	OR8H3 OR2M7 OR2M2 OR2M5 OR2M3 OR2T34 OR2T3 OR56B1 OR2AT4 CNR1 HTR1B GPR22 GPER1 OR4C6 OR10R2 OR10Z1 OR4C12	1.73e-03	677	210	17	PF00001
Domain	FAT	ATR TRRAP	1.83e-03	6	210	2	PS51189
Domain	FATC	ATR TRRAP	1.83e-03	6	210	2	PS51190
Domain	FAT	ATR TRRAP	1.83e-03	6	210	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR TRRAP	1.83e-03	6	210	2	IPR003151
Domain	FATC_dom	ATR TRRAP	1.83e-03	6	210	2	IPR003152
Domain	PIK_FAT	ATR TRRAP	1.83e-03	6	210	2	IPR014009
Domain	FATC	ATR TRRAP	1.83e-03	6	210	2	SM01343
Domain	FN3	LRIT3 USH2A COL12A1 FN1 KALRN TNC LIFR LRRN3	1.90e-03	199	210	8	PS50853
Domain	G_PROTEIN_RECEP_F1_1	OR8H3 OR2M7 OR2M2 OR2M5 OR2M3 OR2T34 OR2T3 OR56B1 OR2AT4 CNR1 HTR1B GPR22 GPER1 OR4C6 OR10R2 OR10Z1 OR4C12	1.95e-03	685	210	17	PS00237
Domain	Peptidase_M14	CPA4 AGBL1 AGBL3	2.10e-03	23	210	3	PF00246
Domain	Peptidase_M14	CPA4 AGBL1 AGBL3	2.10e-03	23	210	3	IPR000834
Domain	G_PROTEIN_RECEP_F1_2	OR8H3 OR2M7 OR2M2 OR2M5 OR2M3 OR2T34 OR2T3 OR56B1 OR2AT4 CNR1 HTR1B GPR22 GPER1 OR4C6 OR10R2 OR10Z1 OR4C12	2.14e-03	691	210	17	PS50262
Domain	GPCR_Rhodpsn	OR8H3 OR2M7 OR2M2 OR2M5 OR2M3 OR2T34 OR2T3 OR56B1 OR2AT4 CNR1 HTR1B GPR22 GPER1 OR4C6 OR10R2 OR10Z1 OR4C12	2.17e-03	692	210	17	IPR000276
Domain	SANT	MTA2 MTA3 MIER1 MTA1	2.39e-03	50	210	4	SM00717
Domain	fn3	USH2A COL12A1 FN1 KALRN TNC LIFR LRRN3	2.41e-03	162	210	7	PF00041
Domain	-	TANC2 ATR TRRAP STIP1 ZC3H7B PPID TTC17 EDRF1	2.42e-03	207	210	8	1.25.40.10
Domain	14_3_3	YWHAG YWHAH	2.55e-03	7	210	2	SM00101
Domain	1433_1	YWHAG YWHAH	2.55e-03	7	210	2	PS00796
Domain	1433_2	YWHAG YWHAH	2.55e-03	7	210	2	PS00797
Domain	14-3-3_domain	YWHAG YWHAH	2.55e-03	7	210	2	IPR023410
Domain	14-3-3_CS	YWHAG YWHAH	2.55e-03	7	210	2	IPR023409
Domain	14-3-3	YWHAG YWHAH	2.55e-03	7	210	2	PF00244
Domain	FN3_dom	LRIT3 USH2A COL12A1 FN1 KALRN TNC LIFR LRRN3	2.57e-03	209	210	8	IPR003961
Domain	SANT/Myb	MTA2 MTA3 MIER1 MTA1	2.76e-03	52	210	4	IPR001005
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYH7 TNIP1 PCDH12 NEB RYR1 MAP3K5 ALMS1 PIK3C2A FDFT1 AGL STIP1 TAF1 COL12A1 NRAP FN1 KALRN DSP DTNA KIF3A PPP1R7 ZSCAN23	1.16e-11	497	222	21	23414517
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 DOCK11 CYTH2 APC2 DLGAP5 MAP3K5 RPTOR PI4KA KCNJ16 STIP1 CPSF2 KIF2C CACNA2D1 AMPD2 KALRN ARHGEF12 GRIN2A GRM3 YWHAG YWHAH KIF3A PPP1R7 TJP1 KIAA1217 UBASH3B PROX1	7.21e-10	963	222	26	28671696
Pubmed	High-throughput microarray detection of olfactory receptor gene expression in the mouse.	OR2M7 OR2M2 OR2M5 OR2M3	1.62e-09	4	222	4	15377787
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 DOCK11 CC2D1A MEF2D PIK3R4 STK3 ALMS1 PIK3C2A RPTOR PI4KA DSTYK BOD1L1 KIF2C AMPD2 STIM2 DSP CBL YWHAG YWHAH TJP1 KIAA1217 KIF13A EDRF1	8.99e-09	861	222	23	36931259
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TANC2 ZHX3 DLGAP5 NOL6 MRPS35 NEB RYR1 TBC1D32 FDFT1 WDR17 FAM149A FAT4 ACOT8 TNC TBC1D25 REV3L CBL ANKRD36B SLFN11	3.48e-08	638	222	19	31182584
Pubmed	The zinc finger and C-terminal domains of MTA proteins are required for FOG-2-mediated transcriptional repression via the NuRD complex.	MTA2 MTA3 ZFPM2 MTA1	1.11e-07	8	222	4	18067919
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CPA4 MTA2 PDS5B DLGAP5 NOL6 TRRAP NCAPG2 DPM1 PIK3R4 PIK3C2A WASHC5 RPTOR PI4KA ANKIB1 UTP20 SCFD1 PHIP KIF2C DCAF13 FN1 DSP ANXA5 TUT7 YWHAG DIS3 NMD3 LLGL1	1.80e-07	1353	222	27	29467282
Pubmed	Identification and characterization of metastasis-associated gene/protein 1 (MTA1).	MTA2 MTA3 MTA1	2.57e-07	3	222	3	25315816
Pubmed	Structure, expression and functions of MTA genes.	MTA2 MTA3 MTA1	2.57e-07	3	222	3	26869315
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	FOXK2 NOL6 MRPS35 ZNF207 TRRAP PWWP2A MTA3 PIK3C2A SCD PI4KA KAT8 UTP20 STIP1 CPSF2 ZC3H7B KIF2C VRK2 ACOT8 PCDHB7 ARHGEF12 CGGBP1 YWHAG CDK5RAP3 MTA1 ARRB1 ZBED6 EDRF1	1.27e-06	1497	222	27	31527615
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	PDS5B ZHX3 NOL6 CC2D1A TRRAP MAP3K5 MTA3 TAF1 PHIP KIF2C AMPD2 ARRB1 TTC17 TBR1 PROX1	2.02e-06	533	222	15	30554943
Pubmed	Endofin is required for HD-PTP and ESCRT-0 interdependent endosomal sorting of ubiquitinated transmembrane cargoes.	CC2D1A TNIP1 ZFYVE9 ALMS1 PIK3C2A CBL	2.37e-06	60	222	6	34761192
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-18	2.54e-06	5	222	3	12629516
Pubmed	The Nucleosome Remodelling and Deacetylation complex suppresses transcriptional noise during lineage commitment.	MTA2 MTA3 MTA1	2.54e-06	5	222	3	31036553
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	TANC2 DOCK11 MAP3K5 WASHC5 PI4KA PHIP CACNA2D1 FN1 KALRN DSP ARHGEF12 YWHAG YWHAH KIF3A	2.62e-06	475	222	14	31040226
Pubmed	Analysis of genes from inner ear developmental-stage cDNA subtraction reveals molecular regionalization of the otic capsule.	OTOR COL2A1 COL12A1 TNC CGGBP1	2.81e-06	35	222	5	15031101
Pubmed	A human MAP kinase interactome.	CYTH2 NEB MEF2D MAP3K5 TAF1 CCDC14 VRK2 DSP LCP2 CBL YWHAG YWHAH KIF3A ARRB1	3.41e-06	486	222	14	20936779
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ZFYVE9 STXBP3 WASHC5 FDFT1 PI4KA MICAL3 STIP1 CPSF2 CCDC14 VRK2 ACOT8 DSP DTNA TNS2 YWHAG YWHAH PPP1R7 PPP2R3A TJP1 CEP135 SLFN11	4.33e-06	1049	222	21	27880917
Pubmed	The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.	MTA2 MTA3 MTA1 UBASH3B	4.61e-06	18	222	4	9790534
Pubmed	Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis.	ITGA4 FN1 TNC PROX1	4.61e-06	18	222	4	19686679
Pubmed	Network organization of the human autophagy system.	MTA2 MAP3K5 PIK3R4 STK3 PIK3C2A RPTOR AGL SCFD1 PRMT7 STIM2 YWHAH LLGL1 TJP1	5.43e-06	437	222	13	20562859
Pubmed	FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.	MTA2 FOXK2 MTA3 MTA1	7.22e-06	20	222	4	27773593
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	MTA2 FOXK2 VWA8 NOL6 ZNF207 CC2D1A TFG DPM1 CIDEA FBXO24 PIK3C2A AGL CPSF2 COL2A1 VRK2 ACOT8 FN1 DSP ANXA5 TUT7 CGGBP1 ANKRD36B TJP1 CKAP2L	8.47e-06	1371	222	24	36244648
Pubmed	Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4.	MTA2 ATR MTA1	8.81e-06	7	222	3	10545197
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	MTA2 MTA3 TAF1 PHIP SFMBT1 MTA1	8.82e-06	75	222	6	25593309
Pubmed	DLL4 promotes continuous adult intestinal lacteal regeneration and dietary fat transport.	FN1 TNC TJP1 PROX1	8.88e-06	21	222	4	26529256
Pubmed	Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.	OTOR BMPR1B HOXD10 CNR1 ALPI COL2A1 COL12A1 TNC TBR1	9.08e-06	210	222	9	16537572
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DIS3L APC2 MRPS35 DPM1 PIK3R4 MTA3 SCG2 TAF1 BACE2 WDR17 FN1 KALRN DSP TMEM59 REV3L YWHAG YWHAH KIF3A NPRL2 MTA1 ARRB1 TJP1 TTC17	9.27e-06	1285	222	23	35914814
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	CC2D1A PBLD CNTLN NEB RYR1 PIK3C2A C19orf18 RHOF CACNA2D1 FN1 ANPEP KALRN DSP ANXA5 TMEM59 ARHGEF12 YWHAG YWHAH KIF3A PPP1R7	9.43e-06	1016	222	20	19056867
Pubmed	Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3.	MTA2 TFG MTA3 RPTOR STIP1 FN1 DSP PPID YWHAG YWHAH MTA1	1.07e-05	332	222	11	30595499
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	MTA2 ZHX3 FOXK2 NOL6 ZNF207 TFG MEF2D CPSF2 PRMT7 VRK2 PPID LLGL1 CKAP2L	1.23e-05	472	222	13	38943005
Pubmed	Atrophin recruits HDAC1/2 and G9a to modify histone H3K9 and to determine cell fates.	MTA2 MIER1 MTA1	1.40e-05	8	222	3	18451879
Pubmed	Cell Adhesion Mediated by VCAM-ITGα9 Interactions Enables Lymphatic Development.	ITGA4 FN1 PROX1	1.40e-05	8	222	3	25745057
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MTA2 PDS5B ATR KIAA0586 NOL6 MRPS35 ZNF207 TFG DPM1 PIK3R4 STXBP3 RPTOR PI4KA UTP20 BOD1L1 STIP1 SCFD1 DNAH5 PHIP DCAF13 DSP ANXA5 DIS3 NMD3	1.59e-05	1425	222	24	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MTA2 TANC2 CYTH2 PIK3R4 WASHC5 RPTOR PI4KA PACS2 MICAL3 STIP1 CACNA2D1 FN1 KALRN DSP TNC ARHGEF12 GRIN2A GRM3 YWHAG YWHAH KIF3A PPP1R7 TJP1 KIAA1217	1.71e-05	1431	222	24	37142655
Pubmed	The functional interactome landscape of the human histone deacetylase family.	MTA2 PWWP2A MTA3 FDFT1 ANKRD12 PHIP MIER1 YWHAG YWHAH MTA1	1.87e-05	289	222	10	23752268
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TANC2 RTEL1 DIS3L KIAA0586 TNIP1 PWWP2A ALMS1 DSTYK MICAL3 PRMT7 STIM2 ATP8B2 CEP135	1.95e-05	493	222	13	15368895
Pubmed	Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.	ITGA4 FN1 TNC	2.10e-05	9	222	3	9882526
Pubmed	Dysfunction of the Reciprocal Feedback Loop between GATA3- and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer Metastasis.	MTA2 MTA3 MTA1	2.10e-05	9	222	3	26028330
Pubmed	Dachsous1-Fat4 Signaling Controls Endothelial Cell Polarization During Lymphatic Valve Morphogenesis-Brief Report.	FAT4 FN1 PROX1	2.10e-05	9	222	3	28705793
Pubmed	RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene.	MTA2 MTA3 MTA1	2.10e-05	9	222	3	22926524
Pubmed	A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.	NOL6 TNIP1 NCAPG2 ALMS1 KIF2C CCDC14 DTNA CEP135 UBASH3B HERC4	2.72e-05	302	222	10	30561431
Pubmed	Development of migrating tendon-bone attachments involves replacement of progenitor populations.	COL2A1 COL12A1 TNC	2.98e-05	10	222	3	30504126
Pubmed	PWWP2B Fine-Tunes Adipose Thermogenesis by Stabilizing HDACs in a NuRD Subcomplex.	MTA2 MTA3 MTA1	2.98e-05	10	222	3	34180153
Pubmed	Recruitment and maintenance of tendon progenitors by TGFbeta signaling are essential for tendon formation.	COL2A1 COL12A1 TNC	2.98e-05	10	222	3	19304887
Pubmed	Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis.	CBL YWHAG YWHAH	2.98e-05	10	222	3	11697890
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-7 ERVK-18 ERVK-25 ERVK-11 ERVK-8	3.22e-05	94	222	6	21542922
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	DIS3L CC2D1A CNTLN STXBP3 ALMS1 WASHC5 MICAL3 CCDC14 DSP TUT7 PPID PPP1R7 PPP2R3A TJP1 KIAA1217 CEP135 TTC17	3.86e-05	853	222	17	28718761
Pubmed	Cbl enforces an SLP76-dependent signaling pathway for T cell differentiation.	LCP2 CBL	4.06e-05	2	222	2	19074136
Pubmed	Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease.	RYR1 IL6	4.06e-05	2	222	2	15299003
Pubmed	Coordination of two kinesin superfamily motor proteins, KIF3A and KIF13A, is essential for pericellular matrix degradation by membrane-type 1 matrix metalloproteinase (MT1-MMP) in cancer cells.	KIF3A KIF13A	4.06e-05	2	222	2	35122963
Pubmed	Expression and alternative splicing of N-RAP during mouse skeletal muscle development.	NOL6 NRAP	4.06e-05	2	222	2	18792955
Pubmed	Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma.	MAP3K5 IL6	4.06e-05	2	222	2	23219526
Pubmed	Counterbalancing anti-adhesive effects of Tenascin-C through fibronectin expression in endothelial cells.	FN1 TNC	4.06e-05	2	222	2	28986537
Pubmed	Bisphenol A triggers proliferation and migration of laryngeal squamous cell carcinoma via GPER mediated upregulation of IL-6.	GPER1 IL6	4.06e-05	2	222	2	28466560
Pubmed	Clinical significance of interleukin‑6 and inducible nitric oxide synthase in ketamine‑induced cystitis.	NOS2 IL6	4.06e-05	2	222	2	29207018
Pubmed	PROX1 restrains ferroptosis via SCD transcription activation in colorectal cancer.	SCD PROX1	4.06e-05	2	222	2	36815375
Pubmed	Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.	ATR REV3L	4.06e-05	2	222	2	28075014
Pubmed	Inhibition of MTA2 and MTA3 induces mesendoderm specification of human embryonic stem cells.	MTA2 MTA3	4.06e-05	2	222	2	33744762
Pubmed	Cleavage of extracellular matrix in periodontitis: gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C.	FN1 TNC	4.06e-05	2	222	2	23313574
Pubmed	Binding of tenascin-C to soluble fibronectin and matrix fibrils.	FN1 TNC	4.06e-05	2	222	2	7499434
Pubmed	PWWP2A binds distinct chromatin moieties and interacts with an MTA1-specific core NuRD complex.	PWWP2A MTA1	4.06e-05	2	222	2	30327463
Pubmed	Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families.	MMP21 PRMT7	4.06e-05	2	222	2	26437029
Pubmed	The association of 14-3-3gamma and actin plays a role in cell division and apoptosis in astrocytes.	YWHAG YWHAH	4.06e-05	2	222	2	12176032
Pubmed	No Association Between Interleukin 6 and Inducible Nitric Oxide Synthase Polymorphisms and Dengue Infection: A Case-Control Study.	NOS2 IL6	4.06e-05	2	222	2	36394557
Pubmed	De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.	FN1 TNC	4.06e-05	2	222	2	24792713
Pubmed	The kinesin-13 MCAK has an unconventional ATPase cycle adapted for microtubule depolymerization.	KIF2C KIF13A	4.06e-05	2	222	2	21873978
Pubmed	Lethal multiple pterygium syndrome, large cystic hygroma, and cleft palate: Rare and severe fetal presentations of RYR1- and NEB-related congenital myopathies.	NEB RYR1	4.06e-05	2	222	2	38520674
Pubmed	Functional analysis of a mouse brain Elk-type K+ channel.	KCNH2 KCNH3	4.06e-05	2	222	2	10191308
Pubmed	Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity.	ERVK-6 ERVK-18	4.06e-05	2	222	2	11672541
Pubmed	Requirement of MTA1 in ATR-mediated DNA damage checkpoint function.	ATR MTA1	4.06e-05	2	222	2	20427275
Pubmed	FOXK2 targeting by the SCF-E3 ligase subunit FBXO24 for ubiquitin mediated degradation modulates mitochondrial respiration.	FOXK2 FBXO24	4.06e-05	2	222	2	38735474
Pubmed	A TNF- and c-Cbl-dependent FLIP(S)-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis.	MAP3K5 CBL	4.06e-05	2	222	2	19597496
Pubmed	Staphylococcal superantigen-like protein 8 (SSL8) binds to tenascin C and inhibits tenascin C-fibronectin interaction and cell motility of keratinocytes.	FN1 TNC	4.06e-05	2	222	2	23485472
Pubmed	A second fibronectin-binding region is present in collagen alpha chains.	COL2A1 FN1	4.06e-05	2	222	2	2229073
Pubmed	In situ hybridization applied to Waardenburg syndrome.	ALPI FN1	4.06e-05	2	222	2	8449034
Pubmed	Tumor-promoting action of ubiquitin protease 43 in gastric cancer progression through deubiquitination and stabilization of stress-inducible phosphoprotein 1.	USP18 STIP1	4.06e-05	2	222	2	37442266
Pubmed	The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor.	CNR1 ARRB1	4.06e-05	2	222	2	35792570
Pubmed	Spondylometaphyseal Dysplasia, Corner Fracture Type	COL2A1 FN1	4.06e-05	2	222	2	32200603
Pubmed	Definition of the native and denatured type II collagen binding site for fibronectin using a recombinant collagen system.	COL2A1 FN1	4.06e-05	2	222	2	24375478
Pubmed	α-Dystrobrevin knockout mice have increased motivation for appetitive reward and altered brain cannabinoid receptor 1 expression.	CNR1 DTNA	4.06e-05	2	222	2	36045406
Pubmed	alpha4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions.	ITGA4 FN1	4.06e-05	2	222	2	19345424
Pubmed	Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis.	FN1 TNC	4.06e-05	2	222	2	20708078
Pubmed	The metastasis-associated genes MTA1 and MTA3 are abundantly expressed in human placenta and chorionic carcinoma cells.	MTA3 MTA1	4.06e-05	2	222	2	19363681
Pubmed	Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma.	FN1 TNC	4.06e-05	2	222	2	30451798
Pubmed	Hepatocyte apical bulkheads provide a mechanical means to oppose bile pressure.	ANPEP TJP1	4.06e-05	2	222	2	36716168
Pubmed	Cannabinoid receptor type 1 (CB1R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3.	CNR1 ARRB1	4.06e-05	2	222	2	37534180
Pubmed	Overexpression of MTA1 inhibits the metastatic ability of ZR-75-30 cells in vitro by promoting MTA2 degradation.	MTA2 MTA1	4.06e-05	2	222	2	30642362
Pubmed	Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.	GPER1 IL6	4.06e-05	2	222	2	27836733
Pubmed	Assignment of the metastasis-associated gene (Mta1) to mouse chromosome band 12F and the metastasis-associated gene 2 (Mta2) to mouse chromosome band 19B by fluorescence in situ hybridization.	MTA2 MTA1	4.06e-05	2	222	2	11856890
Pubmed	Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness.	PI4KA GRM3	4.06e-05	2	222	2	25209194
Pubmed	Cleft palate formation in fetal Br mice with midfacial retrusion: tenascin, fibronectin, laminin, and type IV collagen immunolocalization.	FN1 TNC	4.06e-05	2	222	2	9482226
Pubmed	Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system.	MTA3 MTA1	4.06e-05	2	222	2	25319202
Pubmed	Evaluating the performance of fibronectin 1 (FN1), integrin α4β1 (ITGA4), syndecan-2 (SDC2), and glycoprotein CD44 as the potential biomarkers of oral squamous cell carcinoma (OSCC).	ITGA4 FN1	4.06e-05	2	222	2	23116545
Pubmed	Exome sequencing identifies GRIN2A as frequently mutated in melanoma.	TRRAP GRIN2A	4.06e-05	2	222	2	21499247
Pubmed	GPER negatively regulates TNFα-induced IL-6 production in human breast cancer cells via NF-κB pathway.	GPER1 IL6	4.06e-05	2	222	2	26888479
Pubmed	HOXC4 homeoprotein efficiently expands human hematopoietic stem cells and triggers similar molecular alterations as HOXB4.	HOXB4 HOXC4	4.06e-05	2	222	2	22298821
Pubmed	Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies.	FN1 TNC	4.06e-05	2	222	2	20232238
Pubmed	Melatonin safeguards against fatty liver by antagonizing TRAFs-mediated ASK1 deubiquitination and stabilization in a β-arrestin-1 dependent manner.	MAP3K5 ARRB1	4.06e-05	2	222	2	31541591
Pubmed	Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.	TRRAP USH2A FAT4	4.08e-05	11	222	3	24349473
Interaction	YWHAH interactions	TANC2 DOCK11 CYTH2 CC2D1A MEF2D MAP3K5 PIK3R4 STK3 ALMS1 PIK3C2A CLK2 KCNH2 RPTOR PI4KA PACS2 BOD1L1 KIF2C AMPD2 STIM2 FN1 DSP TNS2 TBC1D25 CBL YWHAG YWHAH ARRB1 TJP1 KIAA1217 CEP135 EDRF1	1.48e-07	1102	200	31	int:YWHAH
Interaction	YWHAG interactions	TANC2 DOCK11 CNTLN ITGA4 TRRAP MEF2D MAP3K5 PIK3R4 STK3 ALMS1 PIK3C2A CLK2 RPTOR PI4KA PACS2 BOD1L1 STIP1 NOS2 KIF2C AMPD2 STIM2 FN1 DSP TNS2 CBL YWHAG YWHAH TGOLN2 ARRB1 TJP1 SLFN11 KIF13A EDRF1	2.32e-07	1248	200	33	int:YWHAG
Interaction	YWHAE interactions	MTA2 TANC2 DOCK11 CYTH2 WASF3 TNIP1 CNTLN ITGA4 MAP3K5 PIK3R4 STK3 STXBP3 PIK3C2A KCNH2 RPTOR KAT8 PACS2 STIP1 NOS2 AMPD2 STIM2 NRAP FN1 TNS2 LCP2 CBL YWHAG YWHAH TGOLN2 ARRB1 TTC17 SLFN11	8.20e-07	1256	200	32	int:YWHAE
Interaction	IGF1R interactions	DPM1 MAP3K5 MTA3 PI4KA SCFD1 KLK5 STIM2 ARHGEF12 CBL YWHAG TGOLN2 NPRL2 CDK5RAP3 ARRB1 LLGL1 DUSP21 TTC17 KIF13A	1.03e-06	467	200	18	int:IGF1R
Interaction	DOCK9 interactions	DOCK11 NEB TAF1 RHOF ANXA5 YWHAG YWHAH	2.37e-06	61	200	7	int:DOCK9
Interaction	ZFPM2 interactions	MTA2 SOX7 MTA3 ZFPM2 MTA1	7.47e-06	28	200	5	int:ZFPM2
Interaction	VCL interactions	ITGA4 ALMS1 AGL SCFD1 PHIP NRAP FN1 YWHAG YWHAH PPP2R3A LLGL1 TJP1 SLFN11	1.19e-05	305	200	13	int:VCL
Interaction	ANKFY1 interactions	DLGAP5 CC2D1A STK3 ZFYVE9 ALMS1 PIK3C2A STIP1 RHOF ARHGEF12 CBL CCDC183	2.51e-05	236	200	11	int:ANKFY1
Interaction	NR3C1 interactions	MTA2 TANC2 ZHX3 DLGAP5 NOL6 MRPS35 NEB RYR1 TBC1D32 FDFT1 WDR17 FAM149A FAT4 ACOT8 DSP TNC TBC1D25 REV3L CBL PPID YWHAH ANKRD36B ARRB1 SLFN11	3.82e-05	974	200	24	int:NR3C1
Interaction	RHOF interactions	TANC2 PDS5B ATR DOCK11 DPM1 STXBP3 PIK3C2A PI4KA UTP20 STIP1 SCFD1 RHOF FAT4 VRK2 STIM2 DIS3 NMD3 LLGL1 TJP1	4.37e-05	673	200	19	int:RHOF
Interaction	SHPRH interactions	MTA2 TRRAP PWWP2A MTA3 FDFT1 YWHAG MTA1	5.16e-05	97	200	7	int:SHPRH
Interaction	EIF5B interactions	FOXK2 ZNF207 TNIP1 BOD1L1 STIP1 FN1 ANXA5 CBL KIF3A SLFN11	5.32e-05	212	200	10	int:EIF5B
Interaction	HSP90AA1 interactions	MTA2 MYH7 ATR TNIP1 MAP3K5 FBXO24 CLK2 KCNH2 RPTOR SCG2 BOD1L1 STIP1 ZC3H7B NOS2 DCAF13 COL12A1 FN1 PPID YWHAG YWHAH NPRL2 ARRB1 LLGL1 TJP1 SLFN11 UBASH3B HERC4 EDRF1	5.45e-05	1263	200	28	int:HSP90AA1
Interaction	JCAD interactions	TRRAP YWHAG YWHAH TJP1 CEP135	5.78e-05	42	200	5	int:JCAD
Interaction	EEF1AKMT3 interactions	FOXK2 RTEL1 MAP3K5 MTA3 PIK3C2A PI4KA STIP1 ZC3H7B ARHGEF12 DIS3 LLGL1 AACS EDRF1	7.46e-05	364	200	13	int:EEF1AKMT3
Cytoband	1q44	OR2M7 OR2M2 OR2M5 OR2M3 OR2T34 OR2T3	1.68e-05	110	222	6	1q44
Cytoband	Ensembl 112 genes in cytogenetic band chr1q44	OR2M7 OR2M2 OR2M5 OR2M3 OR2T34 OR2T3	3.97e-05	128	222	6	chr1q44
GeneFamily	Olfactory receptors, family 2	OR2M7 OR2M2 OR2M5 OR2M3 OR2T34 OR2T3 OR2AT4	4.94e-05	113	153	7	149
GeneFamily	PHD finger proteins\|NuRD complex	MTA2 MTA3 MTA1	1.24e-04	12	153	3	1305
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MTA2 MTA3 MTA1	2.51e-04	15	153	3	82
GeneFamily	Fibronectin type III domain containing	USH2A COL12A1 FN1 KALRN TNC LIFR LRRN3	4.29e-04	160	153	7	555
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF2C KIF6 KIF3A KIF13A	6.10e-04	46	153	4	622
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MTA2 MTA3 MIER1 MTA1	1.05e-03	53	153	4	532
GeneFamily	14-3-3 phospho-serine/phospho-threonine binding proteins	YWHAG YWHAH	1.45e-03	7	153	2	1053
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TANC2 STIP1 ZC3H7B PPID TTC17	2.96e-03	115	153	5	769
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	PDS5B ZHX3 FOXK2 ATR WASF3 DLGAP5 TRRAP RYK PIK3R4 STK3 ZFYVE9 STXBP3 PIK3C2A UTP20 MICAL3 PHIP SFMBT1 REV3L PPP2R3A CEP135 HERC4	5.92e-06	856	210	21	M4500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	TANC2 USP18 OTOR ITGA4 MFAP3L PIK3C2A SCD RPTOR PHIP CNR1 SFMBT1 CACNA2D1 FAT4 GPR22 KALRN DSP PCDHB7 REV3L YWHAG LIFR ARHGAP6 KIF13A	1.01e-05	818	200	22	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	USP18 ZHX3 ZNF207 OTOR MFAP3L PIK3C2A CPSF2 PHIP CNR1 SFMBT1 CACNA2D1 FAT4 KALRN DSP TNC PCDHB7 REV3L GRM3 YWHAG LIFR ARHGAP6	2.59e-05	806	200	21	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	KIAA0586 ALMS1 CLK2 ANKIB1 BOD1L1 PHIP MAP3K19 CACNA2D1 REV3L KIF3A CEP135 CKAP2L	4.15e-05	311	200	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	kidney_adult_RenCorpuscGlomer_k-means-cluster#3_top-relative-expression-ranked_1000	MAP3K5 SCD ANKRD12 TMEM59 ARHGEF12 TNS2 TGOLN2 ARRB1 TJP1	8.94e-05	192	200	9	gudmap_kidney_adult_RenCorpuscGlomer_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	TANC2 PDS5B ZHX3 ZNF207 OTOR ITGA4 MFAP3L PIK3C2A CPSF2 PHIP CNR1 SFMBT1 CACNA2D1 FAT4 GPR22 TNC PCDHB7 REV3L GRM3 LIFR	9.73e-05	818	200	20	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000	ATR KIAA0586 WASF3 NCAPG2 MTA3 ALMS1 UTP20 STIP1 TAF1 PRMT7 KIF2C CCDC14 SFMBT1 LRRC34 DCAF13 DSP TBC1D25 DIS3 NMD3 EDRF1	1.04e-04	822	200	20	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	PCDH12 FAM167B FAT4 STIM2 ARHGEF12 REV3L LIFR TJP1 KIAA1217	6.10e-07	200	216	9	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PCDH12 FAM167B FAT4 STIM2 COL12A1 ARHGEF12 LIFR TJP1 KIAA1217	6.10e-07	200	216	9	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PCDH12 PIK3C2A FAM167B FAT4 COL12A1 ARHGEF12 LIFR TJP1 KIAA1217	6.10e-07	200	216	9	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	NS-control-d_0-4-Myeloid-Mast_cell\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DOCK11 HOXB4 KCNH2 SPATA21 SCG2 CACNA2D1 LCP2 ATP8B2	2.22e-06	174	216	8	2d1f5c17b1551f32f49618ec1bf68eafbfd02ace
ToppCell	ILEUM-inflamed-(7)_Lymphatics\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	WASF3 CIDEA FN1 KALRN DSP TJP1 KIAA1217 PROX1	3.50e-06	185	216	8	d711dd2e91cfee723dae1ccb2b910b8cf3becc3b
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ALMS1 PIK3C2A AGL BOD1L1 ANKRD12 TAF1 ARHGEF12 ARHGAP6	3.64e-06	186	216	8	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-immature_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PCDH12 SOX7 FAM167B FN1 GPER1 PCDHB7 ZFPM2 TJP1	4.60e-06	192	216	8	5af3b2b38495e925497c48f605d618bbf970965d
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CFuPNs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	VRK2 GPR22 GRM3 YWHAH ZNF436-AS1 TBR1 IGSF21 RASGRP2	4.60e-06	192	216	8	a8841ebd879f1c344ab4246fdef77044170f644d
ToppCell	Control-Endothelial\|Control / Disease state, Lineage and Cell class	SOX7 BACE2 KALRN ARHGEF12 ZFPM2 LIFR KIAA1217 PROX1	4.96e-06	194	216	8	485fe5538fabec457b9a51feb641f2a91cbf4e18
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FRMD7 DLGAP5 OTOR NCAPG2 KIF2C CCDC14 REV3L CKAP2L	4.96e-06	194	216	8	7a66bd7d4fc9c6db861cedd2487f241e406869d1
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DLGAP5 ALMS1 PHIP CCDC14 REV3L YWHAH CEP135 SLFN11	4.96e-06	194	216	8	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAP3K5 BMPR1B COL12A1 KALRN TNC REV3L ZFPM2 KIAA1217	5.15e-06	195	216	8	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAP3K5 BMPR1B COL12A1 KALRN TNC REV3L ZFPM2 KIAA1217	5.15e-06	195	216	8	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAP3K5 BMPR1B COL12A1 TNC GRIN2A REV3L ZFPM2 KIAA1217	5.35e-06	196	216	8	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	PCDH12 KALRN ARHGEF12 GRIN2A ZFPM2 ARHGAP6 TJP1 KIAA1217	5.35e-06	196	216	8	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA2D1 FAT4 FN1 KALRN TNC ZFPM2 LIFR ARHGAP6	5.76e-06	198	216	8	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZHX3 WASF3 BMPR1B DTNA REV3L LIFR LRRN3 TJP1	5.98e-06	199	216	8	a900ef002e1ae583b70be0253d8c44dae6754916
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	ITGA4 PCDH12 FAM167B STIM2 ARHGEF12 LIFR TJP1 KIAA1217	6.21e-06	200	216	8	e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCell	Control_saline-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	ITGA4 PCDH12 FAM167B STIM2 ARHGEF12 LIFR TJP1 KIAA1217	6.21e-06	200	216	8	3372c488a39fe812fa94e4f0564594186fea3db5
ToppCell	control-Myeloid-Mast_cell\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DOCK11 HOXB4 KCNH2 SPATA21 SCG2 CACNA2D1 ATP8B2	2.13e-05	172	216	7	c1c99e6732234a6649a79610e99390db0c8f19b0
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0586 RYK ALMS1 DSTYK FAM167B FAT4 ATP8B2	2.56e-05	177	216	7	8ef41ee5d63737b810ad7371b0437625e7e1badf
ToppCell	Endothelial-B-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	PCDH12 BACE2 MAP3K19 GPER1 KALRN LLGL1 PROX1	2.96e-05	181	216	7	4fe0215d08f03d4e24749d70fce01b7aa22906fd
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL12A1 FN1 KALRN TNC REV3L ZFPM2 UBASH3B	3.06e-05	182	216	7	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB USH2A DNAH5 COL2A1 FAT4 COL12A1 KALRN	3.28e-05	184	216	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB USH2A DNAH5 COL2A1 FAT4 COL12A1 KALRN	3.28e-05	184	216	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB USH2A DNAH5 COL2A1 FAT4 COL12A1 KALRN	3.28e-05	184	216	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MFAP3L BMPR1B BACE2 USH2A FAT4 ZBTB7C GRM3	3.40e-05	185	216	7	10da5c2a92bfb3248d3f6f94a0933996326cf590
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZHX3 VWA8 KCNJ16 BACE2 ARHGAP6 PPP2R3A PROX1	3.40e-05	185	216	7	03f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZHX3 VWA8 KCNJ16 BACE2 ARHGAP6 PPP2R3A PROX1	3.52e-05	186	216	7	1850583d23903d08226aeb0edb3e07b0994330e4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZHX3 VWA8 KCNJ16 BACE2 ARHGAP6 PPP2R3A PROX1	3.52e-05	186	216	7	4dafc215c42e7949f932a3627359c107943b5d6b
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SCG2 CNR1 FAT4 COL12A1 LRRN3 SLFN11 PROX1	3.64e-05	187	216	7	02105c82a9ba79d2f19e002188377fc3440770c2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP5 NCAPG2 RYR1 KIF2C LCP2 CKAP2L IGSF21	3.64e-05	187	216	7	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	BMPR1B SCG2 CACNA2D1 GPER1 DSP TJP1 PROX1	3.76e-05	188	216	7	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HOXD10 MICAL3 BACE2 KALRN DSP ZFPM2 PROX1	4.03e-05	190	216	7	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA2D1 FAT4 KALRN TNC ANXA5 GRIN2A ZFPM2	4.03e-05	190	216	7	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA2D1 FAT4 KALRN TNC ANXA5 GRIN2A ZFPM2	4.03e-05	190	216	7	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NCAPG2 RYR1 AGL KIF2C DSP TNC CKAP2L	4.16e-05	191	216	7	0f9443da0f73d07456142fae08b2dc92a5b7b592
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-tip_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PCDH12 SOX7 NOS2 FAM167B CACNA2D1 TNS2 TJP1	4.16e-05	191	216	7	cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NOS2 FAT4 KALRN ARHGEF12 GRIN2A ZFPM2 KIAA1217	4.16e-05	191	216	7	f229abf69a1217194f74b0502486907e07dba989
ToppCell	Control-Myeloid-Macrophage_Alveolar\|Myeloid / Disease state, Lineage and Cell class	TANC2 VWA8 DOCK11 FDFT1 SCD ZBTB7C FN1	4.16e-05	191	216	7	a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9
ToppCell	Monocytes-Tissue-resident_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	TANC2 FAM149A FN1 DTNA ARHGEF12 YWHAH IGSF21	4.45e-05	193	216	7	198552810dcac8d0ca63a78badd6702b49ff6edf
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP5 SPANXB1 KIF2C LRRN3 CKAP2L ZNF700	4.52e-05	132	216	6	f1b448efccbf87caa86d1a794c43a230a4b0758e
ToppCell	(3)_Chondrocytes-(33)_Chondro-prol/rest\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	DLGAP5 FDFT1 SCD KIF2C COL2A1 COL12A1 CKAP2L	4.59e-05	194	216	7	c093c5e161b97ad770bfbaad3023eba4537101b5
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA2D1 FAT4 FN1 KALRN TNC LIFR ARHGAP6	4.59e-05	194	216	7	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	(3)_Chondrocytes-(33)_Chondro-prol/rest\|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis	DLGAP5 NCAPG2 FDFT1 SCD KIF2C LRRN3 CKAP2L	4.59e-05	194	216	7	4a207630d72059345b10010f5cfd3b1462458324
ToppCell	COPD-Endothelial-Lymphatic\|Endothelial / Disease state, Lineage and Cell class	TANC2 BACE2 FN1 KALRN DSP ZFPM2 PROX1	4.75e-05	195	216	7	e91ce548ae7224661ee5d2f2639794a5f69798ee
ToppCell	Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	VRK2 GPR22 GRM3 KIF3A TBR1 IGSF21 RASGRP2	4.75e-05	195	216	7	574354ef4bcefeb9856b65d19bb92e2cffe5dc7a
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DLGAP5 NCAPG2 SOX7 KIF2C FAM167B LIFR CKAP2L	4.90e-05	196	216	7	eb8c9a4a5eb21d43ff7b25deae5896c236f669b9
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DLGAP5 CCDC81 FBXO24 DNAH5 MAP3K19 NRAP CKAP2L	5.06e-05	197	216	7	6e4a411ef823ce9e16f420e185e21fa19d13af34
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	BMPR1B CACNA2D1 COL12A1 TNC ZFPM2 LIFR ARHGAP6	5.23e-05	198	216	7	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	356C-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	KIAA0586 PBLD NEB KCNJ16 ARHGEF12 ZNF101	5.34e-05	136	216	6	edfd453c9a650d69d05a5a3ab15f7df56349fa86
ToppCell	356C-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	KIAA0586 PBLD NEB KCNJ16 ARHGEF12 ZNF101	5.34e-05	136	216	6	03e4e2353c23ceffde35b2d0aadd15299e3db09f
ToppCell	Fetal_29-31_weeks\|World / Lineage, Cell type, age group and donor	FAT4 COL12A1 FN1 KALRN TNC ZFPM2 LIFR	5.39e-05	199	216	7	5b9d355795dd03a22f0961dfd143425c367a4654
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	COL12A1 FN1 KALRN TNC GRIN2A REV3L ZFPM2	5.39e-05	199	216	7	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control_saline / Treatment groups by lineage, cell group, cell type	ITGA4 PCDH12 FAM167B ARHGEF12 LIFR TJP1 KIAA1217	5.57e-05	200	216	7	041a34080120c9f613373c20dcc366292f558040
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ITGA4 PCDH12 FAM167B ARHGEF12 ARHGAP6 TJP1 KIF13A	5.57e-05	200	216	7	7034f57e282982c19c13ee8ab78eabaffa069e30
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	ITGA4 PCDH12 BACE2 FAM167B ARHGEF12 TJP1 KIAA1217	5.57e-05	200	216	7	432384faeade8e609154fab3d96c955a8ec868dd
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PCDH12 FAM167B FAT4 ARHGEF12 LIFR TJP1 KIAA1217	5.57e-05	200	216	7	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb\|Cerebellum / BrainAtlas - Mouse McCarroll V32	CIDEA ANKRD12 CNR1 GPR22 ZFPM2 SKOR1	8.86e-05	149	216	6	6e9ca280a599d96f8956ef26f2a46b9484de5488
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	STIM2 COL12A1 YWHAH ZFPM2 TBR1 IGSF21	9.19e-05	150	216	6	9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	STIM2 COL12A1 YWHAH ZFPM2 TBR1 IGSF21	1.02e-04	153	216	6	b37a1ecad389d2848b8ca4d287823e8048207420
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	CPAMD8 OR56B1 DNAH5 AGBL1 FAM149A KIAA1217	1.45e-04	163	216	6	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA4 USH2A FN1 ARHGAP6 IGSF21 RASGRP2	1.55e-04	165	216	6	ab6ed7e30096c418e7be2d5eec33feeddd1387d9
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCG2 COL12A1 FN1 TNC PCDHB7 SKOR1	1.65e-04	167	216	6	31cf8bf2eb523f6e7e319620648ff37fc09e2601
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCG2 COL12A1 FN1 TNC PCDHB7 SKOR1	1.65e-04	167	216	6	805129f887078340b260aa136b0ba19f2bd6ea03
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCG2 COL12A1 FN1 TNC PCDHB7 SKOR1	1.65e-04	167	216	6	3acb18428d1d33ad430c2fd031b1a91baee3c01d
ToppCell	Dividing_Macrophages-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	DLGAP5 NCAPG2 KIF2C FN1 YWHAH CKAP2L	1.76e-04	169	216	6	bc859a103cad567caf50c3c3882d2d2017807c73
ToppCell	BL-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KCNH2 SCG2 CACNA2D1 FAT4 GPER1 PROX1	1.82e-04	170	216	6	b465df2dac6b4e98b4ede6ad0c6347656757885c
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PCDH12 WASHC5 ANXA5 LCP2 PPID NGLY1	1.94e-04	172	216	6	965a9f62b73a7e3531c343121a7c507b7e1bfe05
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	DOCK11 MAP3K5 ZBTB7C TNC DTNA ZFPM2	1.94e-04	172	216	6	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	KCNH2 MICAL3 CACNA2D1 KALRN TNC DTNA	1.94e-04	172	216	6	c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCell	Endothelial-Endothelial-G\|Endothelial / shred on cell class and cell subclass (v4)	LAX1 HOXD10 FN1 ANPEP UBASH3B PROX1	1.94e-04	172	216	6	644f8e42ee8d8996f6ae50cdf874559be55509fc
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CIDEA FAT4 COL12A1 ZBTB7C ARHGAP6 KIAA1217	2.07e-04	174	216	6	912a9e892b29d945666fc37c986009c97c668ac8
ToppCell	PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MFAP3L KALRN ARHGAP6 LRRN3 UBASH3B RASGRP2	2.07e-04	174	216	6	a3f4981b10afa9d41a1c66c7f98522a8a534f82b
ToppCell	PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MFAP3L KALRN ARHGAP6 LRRN3 UBASH3B RASGRP2	2.07e-04	174	216	6	6cc108dde4b3f98a78a6040280f0d5e4aaa5bd75
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MTA2 USP18 SOX7 EEF1AKMT1 ZNF700 PROX1	2.07e-04	174	216	6	4a18b51501eaaeb7907e99316ba8ae15b2c7d529
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CIDEA ZBTB7C ZFPM2 ARHGAP6 KIAA1217 TBR1	2.07e-04	174	216	6	e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCell	PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MFAP3L KALRN ARHGAP6 LRRN3 UBASH3B RASGRP2	2.07e-04	174	216	6	4b8bc5568e36031c8ecf001bb646809038c23919
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NOL6 CLK2 GPR22 DSP TNC LLGL1	2.07e-04	174	216	6	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DLGAP5 RYR1 KIF2C DSP TNC CKAP2L	2.13e-04	175	216	6	9142ed8ca2f1c0c518deb21988221406f62fe38c
ToppCell	severe_influenza-Plasmablast\|World / disease group, cell group and cell class (v2)	CCDC168 KIF2C FAM149A CKAP2L EEF1AKMT1 ZSCAN23	2.13e-04	175	216	6	e6d6c44510d5dc4eb0bae820125e42366f7a4e74
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 COL12A1 FN1 KALRN TNC ZFPM2	2.20e-04	176	216	6	9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 COL12A1 FN1 KALRN TNC ZFPM2	2.20e-04	176	216	6	3f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122\|Adult / Lineage, Cell type, age group and donor	CPAMD8 DNAH5 AGBL1 FAM149A LIFR KIAA1217	2.20e-04	176	216	6	3fee8a367bb9755aca1b7fcc968b08e51b6e9436
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KALRN LCP2 YWHAH ARHGAP6 LRRN3 UBASH3B	2.33e-04	178	216	6	9e1f2596fcea5b79cc50b58d83706bb8605e224f
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZHX3 DLGAP5 HOXB4 DSTYK PGGHG AACS	2.33e-04	178	216	6	c87945146b2734141f07b39d268e0d8086ee0364
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KALRN LCP2 YWHAH ARHGAP6 LRRN3 UBASH3B	2.33e-04	178	216	6	aa659bd283c4dfbe292cd8698bbf6b1999ca3314
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK11 OR2M5 AGBL1 COL12A1 MYRFL KIAA1217	2.33e-04	178	216	6	6ad46b0720298bcb927fd53468bb4ea0c199ad35
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCDH12 NEB SOX7 FAM167B GPER1 UBASH3B	2.33e-04	178	216	6	60263c0bb9de3a57ba2ba543262a2ace0066fd85
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 GPR22 GRIN2A ZFPM2 ARRB1 KIAA1217	2.33e-04	178	216	6	78a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KALRN LCP2 YWHAH ARHGAP6 LRRN3 UBASH3B	2.33e-04	178	216	6	bf1d273802a4f42e52ea1bd2a0cae2039559c093
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP5 NCAPG2 MICAL3 KIF2C CCDC14 LRRC34	2.41e-04	179	216	6	4166c4e1a8748a79ac6a11fd0b97c5344be2321b
ToppCell	ILEUM-non-inflamed-(7)_Lymphatics\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	WASF3 FN1 KALRN DSP TJP1 PROX1	2.41e-04	179	216	6	99777a8931356d1206b8ab22aaa1b1d5a600b809
ToppCell	368C-Endothelial_cells-Endothelial-E\|368C / Donor, Lineage, Cell class and subclass (all cells)	RTEL1 PCDH12 SOX7 FAM167B GPER1 KIAA1217	2.48e-04	180	216	6	8ab16a0b9053bffc07b569a4f9e71749f56dde7e
ToppCell	368C-Endothelial_cells-Endothelial-E-\|368C / Donor, Lineage, Cell class and subclass (all cells)	RTEL1 PCDH12 SOX7 FAM167B GPER1 KIAA1217	2.48e-04	180	216	6	394cd465b88429b70eebb2957480dffcbc51cfe7
ToppCell	LPS-IL1RA-Endothelial-Epi-like\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RYK FBXO24 KIF6 ZNF101 CCDC183	2.53e-04	116	216	5	cf4e3c34570f57502ec524881d351ef8e47976d2
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SCG2 CNR1 FAT4 COL12A1 LRRN3 PROX1	2.55e-04	181	216	6	2f3d04d22d4ac016e61709ea5af3d48885c946c4
ToppCell	critical-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	WASF3 LAX1 KCNH2 BACE2 CACNA2D1 ARHGAP6	2.55e-04	181	216	6	f0d81ae74d3f32979624a94b2ef93774831a7970
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYK ALMS1 BACE2 FAM167B FAT4 ATP8B2	2.55e-04	181	216	6	4df7972f88117108698efd06b124b232f8588981
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNA2D1 FAT4 COL12A1 FN1 TNC DTNA	2.55e-04	181	216	6	b116c68393d8836bac080f81a8fcbeb52e0403e7
Drug	Solanine alpha [20562-02-1]; Up 200; 4.6uM; HL60; HT_HG-U133A	ZHX3 RTEL1 LAX1 HOXC4 KCNH2 GNAT2 ZC3H7B FAM149A TNC KIF13A EDRF1	2.41e-06	195	213	11	2152_UP
Drug	natrin	RYR1 KCNH2 CACNA2D1	3.21e-06	4	213	3	CID000019130
Drug	theaflavin gallate	TFG PHIP ANXA5	7.96e-06	5	213	3	CID000169167
Drug	Quinoxaline	AGL PHIP HTR1B GRIN2A GRM3 PPID	8.88e-06	52	213	6	CID000007045
Drug	Gly-pro-arg	PIK3R4 ZFYVE9 KLK5 CNR1 FN1	1.12e-05	32	213	5	CID000170776
Drug	6-methylenetestosterone acetate	MTA2 MTA3 MTA1	1.58e-05	6	213	3	CID000159323
Drug	Kanamycin A sulfate [25389-94-0]; Up 200; 6.8uM; PC3; HT_HG-U133A	APC2 ITGA4 NEB LAX1 MFAP3L ALPI GPR22 FN1 TBR1 HERC4	1.75e-05	197	213	10	4625_UP
Drug	Flunarizine dihydrochloride [30484-77-6]; Down 200; 8.4uM; HL60; HT_HG-U133A	MTA2 VWA8 RTEL1 LAX1 MICAL3 KLK5 SFMBT1 MARCHF8 ARHGEF12 ATP8B2	1.83e-05	198	213	10	2381_DN
Drug	Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	KIAA0586 NOL6 NEB MFAP3L DSTYK KAT8 ZC3H7B GPER1 PPP2R3A KIF13A	1.83e-05	198	213	10	5420_DN
Drug	Riboflavine [83-88-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A	VWA8 RTEL1 KIAA0586 MFAP3L ZFYVE9 KCNH2 MICAL3 KLK5 DTNA PPP2R3A	1.91e-05	199	213	10	2760_DN
Disease	Seizures	TANC2 APC2 TRRAP FDFT1 KAT8 PACS2 NOS2 CNR1 HTR1B IL6	3.55e-06	218	207	10	C0036572
Disease	Asthma	TNIP1 DNAH5 NOS2 TNC KIF3A IL6	2.16e-05	80	207	6	C0004096
Disease	SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE	COL2A1 FN1	4.90e-05	2	207	2	184255
Disease	Spondylometaphyseal dysplasia - Sutcliffe type	COL2A1 FN1	4.90e-05	2	207	2	cv:C0432221
Disease	Spondylometaphyseal dysplasia, 'corner fracture' type	COL2A1 FN1	4.90e-05	2	207	2	C0432221
Disease	migraine without aura, susceptibility to, 4, age at onset	NOL6 NRAP	4.90e-05	2	207	2	EFO_0004847, MONDO_0011847
Disease	Autistic Disorder	VWA8 ITGA4 TRRAP KAT8 NOS2 HTR1B GRIN2A TBR1 IL6	1.02e-04	261	207	9	C0004352
Disease	visceral heterotaxy (implicated_via_orthology)	MMP21 CC2D1A TBC1D32 DNAH5	1.30e-04	37	207	4	DOID:0050545 (implicated_via_orthology)
Disease	migraine disorder, age at onset	NOL6 NRAP	1.46e-04	3	207	2	EFO_0004847, MONDO_0005277
Disease	Cardiovascular Abnormalities	APC2 KAT8 NOS2	1.78e-04	16	207	3	C0243050
Disease	Short QT Syndrome 1	KCNH2 CACNA2D1	2.91e-04	4	207	2	C1865020
Disease	Usher syndrome (is_implicated_in)	USH2A USH1C	2.91e-04	4	207	2	DOID:0050439 (is_implicated_in)
Disease	osteochondrodysplasia (is_implicated_in)	BMPR1B COL2A1 LIFR	3.03e-04	19	207	3	DOID:2256 (is_implicated_in)
Disease	Usual Interstitial Pneumonia	RTEL1 GPER1 DSP	3.03e-04	19	207	3	C4721509
Disease	Hamman-Rich Disease	RTEL1 GPER1 DSP	3.03e-04	19	207	3	C4721508
Disease	Cardiomyopathies	MYH7 MAP3K5 DSP DTNA YWHAH IL6	3.21e-04	130	207	6	C0878544
Disease	Intellectual Disability	TANC2 APC2 PCDH12 TFG TRRAP FDFT1 KAT8 PACS2 TAF1 PHIP YWHAG	3.44e-04	447	207	11	C3714756
Disease	alpha-tocopherol measurement	USH2A CACNA2D1 IL6	3.55e-04	20	207	3	EFO_0007898
Disease	Familial Idiopathic Pulmonary Fibrosis	RTEL1 GPER1 DSP	3.55e-04	20	207	3	C4721952
Disease	melanoma	TRRAP MAP3K5 STIP1 COL2A1 FAT4 TNC GRIN2A GRM3	3.86e-04	248	207	8	C0025202
Disease	Idiopathic Pulmonary Fibrosis	RTEL1 GPER1 DSP	4.12e-04	21	207	3	C1800706
Disease	Huntington's disease (is_implicated_in)	MAP3K5 GRIN2A IL6	5.43e-04	23	207	3	DOID:12858 (is_implicated_in)
Disease	prostate carcinoma	TANC2 RTEL1 DPM1 PHIP COL2A1 CACNA2D1 VRK2 ZBTB7C GPER1 TNC MARCHF8 DIS3 PPP1R7 ARHGAP6 KIF13A IL6	5.89e-04	891	207	16	EFO_0001663
Disease	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	NEB RYR1	7.21e-04	6	207	2	C1854678
Disease	diabetic angiopathy (implicated_via_orthology)	NOS2 FN1	7.21e-04	6	207	2	DOID:11713 (implicated_via_orthology)
Disease	Congenital myopathy with fiber type disproportion	MYH7 RYR1	7.21e-04	6	207	2	cv:C0546264
Disease	Weight Gain	RYK CNR1 STIM2 ANXA5 ARHGEF12	7.77e-04	102	207	5	C0043094
Disease	coronary artery disease	PDS5B ZHX3 WASF3 STK3 BMPR1B RPTOR DSTYK RHOF COL2A1 FAT4 FN1 ARHGEF12 ZFPM2 LYRM2 PPP2R3A ZBED6 KIAA1217 CEP135 UBASH3B	7.95e-04	1194	207	19	EFO_0001645
Disease	Spondylometaphyseal dysplasia	COL2A1 FN1	1.00e-03	7	207	2	cv:C4759767
Disease	Type II Collagenopathies	COL2A1 FN1	1.00e-03	7	207	2	cv:CN043672
Disease	glypican-1 measurement	NOL6 NRAP	1.00e-03	7	207	2	EFO_0801649
Disease	monocyte count	ITGA4 MEF2D RYR1 MAP3K5 C11orf40 CLK2 FDFT1 PI4KA KCNJ16 STIP1 MAP3K19 ZBTB7C FN1 KALRN ARHGEF12 CBL MIER1 ZFPM2 AGBL3 UBASH3B	1.05e-03	1320	207	20	EFO_0005091
Disease	carcinoma (implicated_via_orthology)	STK3 SCD FAT4 LLGL1	1.08e-03	64	207	4	DOID:305 (implicated_via_orthology)
Disease	pulmonary hypertension (is_marker_for)	BMPR1B NOS2 TNC IL6	1.08e-03	64	207	4	DOID:6432 (is_marker_for)
Disease	Chronic Obstructive Airway Disease	NOS2 DSP IL6	1.59e-03	33	207	3	C0024117
Disease	Chronic Airflow Obstruction	NOS2 DSP IL6	1.59e-03	33	207	3	C1527303
Disease	response to diuretic, low density lipoprotein cholesterol measurement	CPSF2 PHIP	1.71e-03	9	207	2	EFO_0004611, GO_0036270
Disease	Major Depressive Disorder	CC2D1A CNR1 HTR1B ANPEP KALRN ARRB1 IL6	1.71e-03	243	207	7	C1269683
Disease	platelet measurement	DLGAP5 PWWP2A RHOF KALRN CBL ZFPM2 CKAP2L IL6	1.80e-03	315	207	8	EFO_0005036
Disease	Inflammatory Bowel Diseases	APC2 ITGA4 IL6	1.89e-03	35	207	3	C0021390
Disease	Cannabis Abuse	FDFT1 CNR1	2.12e-03	10	207	2	C0006868
Disease	Cannabis-Related Disorder	FDFT1 CNR1	2.12e-03	10	207	2	C0236735
Disease	Abnormality of nervous system morphology	APC2 FDFT1	2.12e-03	10	207	2	C4022810
Disease	Pleural Diseases	TNC IL6	2.12e-03	10	207	2	C0032226
Disease	Hashish Abuse	FDFT1 CNR1	2.12e-03	10	207	2	C0018614
Disease	glucagon-like peptide-1 measurement	AGBL1 COL12A1	2.12e-03	10	207	2	EFO_0008465
Disease	abdominal aortic calcification measurement	NOL6 PIK3R4	2.12e-03	10	207	2	EFO_0010272
Disease	long QT syndrome (implicated_via_orthology)	KCNH2 ARHGAP6	2.12e-03	10	207	2	DOID:2843 (implicated_via_orthology)
Disease	mean platelet volume	PDS5B FOXK2 DOCK11 DIS3L DLGAP5 PWWP2A SCD PI4KA DSTYK STIP1 RHOF PHIP KALRN ZFPM2 CKAP2L UBASH3B	2.37e-03	1020	207	16	EFO_0004584
Disease	Unipolar Depression	CC2D1A CNR1 HTR1B ANPEP KALRN ARRB1 IL6	2.44e-03	259	207	7	C0041696
Disease	Global developmental delay	APC2 TRRAP KAT8 PACS2 TAF1	2.52e-03	133	207	5	C0557874
Disease	Retinal Detachment	CPAMD8 COL2A1	2.58e-03	11	207	2	C0035305
Disease	spontaneous preterm birth, parental genotype effect measurement	CACNA2D1 IL6	2.58e-03	11	207	2	EFO_0005939, EFO_0006917
Disease	interstitial collagenase measurement	MEF2D ZFPM2	2.58e-03	11	207	2	EFO_0008193
Disease	Shortened QT interval	KCNH2 CACNA2D1	2.58e-03	11	207	2	C0151879
Disease	cognitive function measurement	TANC2 TNIP1 OTOR ALMS1 BACE2 USH2A DNAH5 AGBL1 SFMBT1 VRK2 HTR1B KALRN DSP GRIN2A GRM3 PRPF18 ZFPM2 KCNH3 NMD3 KIAA1217	2.78e-03	1434	207	20	EFO_0008354
Disease	mean arterial pressure	RYK HOXC4 SCD RPTOR PHIP STIM2 ARHGEF12 TNS2 KIAA1217 UBASH3B	2.90e-03	499	207	10	EFO_0006340
Disease	Allodynia	NOS2 CNR1 CACNA2D1 IL6	2.93e-03	84	207	4	C0458247
Disease	Mechanical Allodynia	NOS2 CNR1 CACNA2D1 IL6	2.93e-03	84	207	4	C2936719
Disease	Hyperalgesia, Secondary	NOS2 CNR1 CACNA2D1 IL6	2.93e-03	84	207	4	C0751212
Disease	Hyperalgesia, Primary	NOS2 CNR1 CACNA2D1 IL6	2.93e-03	84	207	4	C0751211
Disease	Hyperalgesia, Thermal	NOS2 CNR1 CACNA2D1 IL6	2.93e-03	84	207	4	C0751214
Disease	Tactile Allodynia	NOS2 CNR1 CACNA2D1 IL6	2.93e-03	84	207	4	C0751213
Disease	Hyperalgesia	NOS2 CNR1 CACNA2D1 IL6	2.93e-03	84	207	4	C0020429
Disease	Parkinson Disease	NCAPG2 MAP3K5 MTA1 IL6	3.06e-03	85	207	4	C0030567
Disease	cortical surface area measurement	CPA4 TANC2 ZHX3 CPAMD8 CNTLN DSTYK KCNJ16 AGBL1 COL2A1 CACNA2D1 KIF6 VRK2 TUT7 ARHGEF12 PRPF18 TGOLN2 NPRL2 TJP1 IL6	3.07e-03	1345	207	19	EFO_0010736
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	SOX7 ZFPM2	3.09e-03	12	207	2	DOID:3827 (implicated_via_orthology)
Disease	Congenital myopathy (disorder)	NEB RYR1	3.09e-03	12	207	2	C0270960
Disease	disks large homolog 3 measurement	MEF2D ZFPM2	3.09e-03	12	207	2	EFO_0802472
Disease	lung disease (implicated_via_orthology)	NOS2 IL6	3.63e-03	13	207	2	DOID:850 (implicated_via_orthology)
Disease	Autosomal Dominant Myotubular Myopathy	MYH7 RYR1	3.63e-03	13	207	2	C3661489
Disease	Centronuclear myopathy	MYH7 RYR1	3.63e-03	13	207	2	C0175709
Disease	X-linked centronuclear myopathy	MYH7 RYR1	3.63e-03	13	207	2	C0410203
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH7 SCD	3.63e-03	13	207	2	DOID:397 (implicated_via_orthology)
Disease	Myopathy, Centronuclear, 1	MYH7 RYR1	3.63e-03	13	207	2	C4551952
Disease	iron deficiency anemia (biomarker_via_orthology)	FN1 IL6	3.63e-03	13	207	2	DOID:11758 (biomarker_via_orthology)
Disease	Sjogren's Syndrome	TNIP1 PHIP	3.63e-03	13	207	2	C1527336
Disease	Sicca Syndrome	TNIP1 PHIP	3.63e-03	13	207	2	C0086981
Disease	Congenital Structural Myopathy	MYH7 RYR1	3.63e-03	13	207	2	C0752282
Disease	Disorder of eye	LRIT3 ALMS1 GNAT2 USH2A COL2A1 USH1C	3.94e-03	212	207	6	C0015397
Disease	Myopathy, Centronuclear, Autosomal Dominant	MYH7 RYR1	4.22e-03	14	207	2	C1834558
Disease	tetralogy of Fallot (implicated_via_orthology)	DNAH5 ZFPM2	4.22e-03	14	207	2	DOID:6419 (implicated_via_orthology)
Disease	Hamman-Rich syndrome	RTEL1 DSP	4.22e-03	14	207	2	C0085786
Disease	Tobacco Dependence	RPTOR IL6	4.22e-03	14	207	2	C0040332
Disease	Tubular Aggregate Myopathy	MYH7 RYR1	4.22e-03	14	207	2	C0410207
Disease	silicosis (biomarker_via_orthology)	RTEL1 KIF3A	4.22e-03	14	207	2	DOID:10325 (biomarker_via_orthology)
Disease	Hypothermia, natural	NOS2 CNR1	4.22e-03	14	207	2	C0020672
Disease	Nicotine Dependence	RPTOR IL6	4.22e-03	14	207	2	C0028043
Disease	Left ventricular noncompaction	MYH7 DTNA	4.22e-03	14	207	2	C1960469
Disease	extrinsic allergic alveolitis (is_marker_for)	NOS2 TNC	4.22e-03	14	207	2	DOID:841 (is_marker_for)
Disease	Kuhnt-Junius degeneration (is_marker_for)	ANXA5 IL6	4.22e-03	14	207	2	DOID:10873 (is_marker_for)
Disease	Nicotine Use Disorder	RPTOR IL6	4.22e-03	14	207	2	C0376384
Disease	obesity (implicated_via_orthology)	STK3 ALMS1 CNR1 FAT4 STIM2 PROX1	4.22e-03	215	207	6	DOID:9970 (implicated_via_orthology)
Disease	response to hydrochlorothiazide, triglyceride measurement	AGBL1 GRIN2A ARRB1	4.40e-03	47	207	3	EFO_0004530, EFO_0005202
Disease	Myocardial Infarction	MYH7 NOS2 KIF6 IL6	4.55e-03	95	207	4	C0027051
Disease	matrix metalloproteinase 1 measurement	ZFPM2 CKAP2L	4.84e-03	15	207	2	EFO_0010588
Disease	Situs ambiguus	MMP21 DNAH5	4.84e-03	15	207	2	C0266642
Disease	impotence (implicated_via_orthology)	CNR1 IL6	4.84e-03	15	207	2	DOID:1875 (implicated_via_orthology)
Disease	Autosomal Recessive Centronuclear Myopathy	MYH7 RYR1	4.84e-03	15	207	2	C3645536
Disease	Craniofacial Abnormalities	KIAA0586 RYK BMPR1B COL2A1 KIF3A	4.97e-03	156	207	5	C0376634

Protein segments in the cluster

Peptide	Gene	Start	Entry
QVEYDQLTPRRSRKL	USH1C	71	Q9Y6N9
PLSNEERNLLSVAYK	YWHAG	36	P61981
TLIDQYLRDPNLQKR	ACOT8	156	O14734
PKISIYLRDENSSRS	BACE2	356	Q9Y5Z0
IYVEARSRILKQTPN	HTR1B	231	P28222
SDRSKTLYLQQRIFP	AGBL3	476	Q8NEM8
PTRVNREKYKNITAQ	CNTLN	961	Q9NXG0
TYVQPRRKQRDEQLL	CPSF2	206	Q9P2I0
VRNQDLPNKTEYSLR	TBC1D32	806	Q96NH3
PLSNEDRNLLSVAYK	YWHAH	36	Q04917
YVSSRENIDLSKIPN	AACS	241	Q86V21
VRENCKPLRRYLTSE	CLK2	431	P49760
YDSVIRELLQKPNAR	GRM3	256	Q14832
KVASALDRERIPSYN	FAT4	421	Q6V0I7
VKANDQAVPIETRRY	FAT4	1496	Q6V0I7
YSRREKPSVISQQEL	ALMS1	1941	Q8TCU4
ERQQLESLYKNLRIP	C19orf18	131	Q8NEA5
TEDLAQKVNRPYLRT	ANKIB1	691	Q9P2G1
SYTLNPDLIRKQDAT	ANPEP	846	P15144
NEYQPLLLAVSRRKV	ANKRD36B	151	Q8N2N9
YRRLILKTQIPEASD	ZNF436-AS1	86	Q8NC38
ARNRSKTALYVTPLD	CGGBP1	11	Q9UFW8
SRTPEELRAIKQVYE	ANXA5	116	P08758
TRRYLQQLAEKPLET	AMPD2	266	Q01433
YVSADRNLIKNTAPV	ANKRD12	1381	Q6UB98
KRQETRPRYSIGLEQ	BMPR1B	151	O00238
LENRSNSRPLESKRY	CCDC14	131	Q49A88
LSRNPDNYVRETKLD	DCAF13	6	Q9NV06
EVPREYIRALNATKL	DCAF13	36	Q9NV06
ELEVRSPRQNKYSVL	DPM1	16	O60762
VYTLTPFLANNREKR	ARRB1	271	P49407
PYQCTQRLLERTKNE	AGBL1	996	Q96MI9
DYNRTPAQRLLKEIQ	ARHGEF12	226	Q9NZN5
KPDLSDTVRYTQLVR	ATP8B2	1111	P98198
EYRSQKTSRLPIIDI	COL2A1	1451	P02458
LLKRTAQAIEPYITN	PDS5B	221	Q9NTI5
PYLVRRIEELNKTAN	MTA2	21	O94776
PDTQKLLVRLSDVYN	PBLD	156	P30039
PRNLVKEQRVYQEAT	OTOR	101	Q9NRC9
TRINATLETKQPRQY	MYH7	441	P12883
EKSRYEVSTRENNLP	PCDH12	461	Q9NPG4
YGPDTSELVRQQIRK	KCNH3	71	Q9ULD8
DATQASYRIRESPKL	LLGL1	956	Q15334
RQRLEALCQPSEYSK	NOS2	856	P35228
NPVVYTLRNAEVKSA	OR4C12	281	Q96R67
AIKAINLNRPILYSE	LRRC34	236	Q8IZ02
ADRDEVYTIPNSLKR	MFAP3L	281	O75121
PRTYTEEELNAKLTR	MICAL3	1816	Q7RTP6
RNLLKRVYPDSIQEL	PRAMEF17	196	Q5VTA0
NILRNPNDEKYRSIR	NGLY1	41	Q96IV0
ELYQLSLQREPRSKS	RASGRP2	376	Q7LDG7
QYTISKDEPLFLQAR	NRAP	761	Q86VF7
QRLKTPNIYSDEVLR	FAM149A	621	A5PLN7
TLQQDYAPLSRKAQE	EDRF1	976	Q3B7T1
SLNRYFIKVPRSQEE	FOXK2	311	Q01167
YLSELAEQPERKITR	KAT8	126	Q9H7Z6
ETDRKHLAQTRYLPN	FRMD7	136	Q6ZUT3
ERNSPDVSYERSIIK	ZFPM2	901	Q8WW38
DSDLVRYRTISKIPQ	KCNH2	321	Q12809
PTISLEFRNLAEKYQ	FDFT1	126	P37268
VNRNRVLNSYPKRIT	MMP21	476	Q8N119
NPLIYSLRNKEVTRA	OR2M2	286	Q96R28
NPLIYSLRNKEVTRA	OR2M3	286	Q8NG83
NPLIYSLRNKEVTRA	OR2M5	286	A3KFT3
NPLIYSLRNKEVTRA	OR2M7	286	Q8NG81
TSIQDLKYVRDALQP	PIK3C2A	1346	O00443
LKYVRDALQPQTTDA	PIK3C2A	1351	O00443
DENDRYVPNLLKSLR	HERC4	226	Q5GLZ8
QSPIEYQRKERSTAV	KALRN	2236	O60229
YKEPTNEELNRLRET	NOL6	61	Q9H6R4
NPTVYALQTKELRAA	OR56B1	296	Q8NGI3
SAPSVYQKLRELCRE	EEF1AKMT1	81	Q8WVE0
LYILSLKDQDRRVPN	MYRFL	646	Q96LU7
IKTPYQSAQRAELVA	HERVK_113	486	P63132
PNATIRNVLREKIYS	PI4KA	1366	P42356
PRTLSYIFEQLQKDS	KIF6	121	Q6ZMV9
TLPQTRQRAKNIYDI	LAX1	81	Q8IWV1
INLPYKDLTSEVTRR	MYOCOS	11	A0A1B0GUC4
IPSQDAISARVYRSK	MARCHF8	11	Q5T0T0
VLSQKRCEDAYPRQI	KLK5	211	Q9Y337
ITSVPNEALRYLKNL	LRIT3	141	Q3SXY7
FSLSPDVRRKNLEIY	PGGHG	511	Q32M88
NPLIYSLRNKDVTRA	OR2T34	291	Q8NGX1
NPLIYSLRNKDVTRA	OR2T3	291	Q8NH03
DARSQLQIPRKTVYD	PACS2	461	Q86VP3
SKQLDVYNLTARPII	KIF3A	71	Q9Y496
SLYNLEVNDPRTLKA	PPP2R3A	376	Q06190
IKTPYQSAQRAELVA	ERVK-7	486	P63135
IKTPYQSAQRAELVA	ERVK-6	486	Q9BXR3
QRDLQITPKRLEYTR	DSTYK	381	Q6XUX3
NPLIYSLRNREVKNA	OR8H3	286	Q8N146
RPKASYSLERDQLIA	OR10Z1	261	Q8NGY1
EPKRSRTAYTRQQVL	HOXB4	161	P17483
LALSKTYNVDRQVPD	ALPI	96	P09923
LKNFYTLVTERPLDR	PCDHB4	396	Q9Y5E5
PDVVDYLLRRKASQS	ARHGAP6	621	O43182
IKTPYQSAQRAELVA	ERVK-18	486	Q9QC07
EKPLDRERNTEYNIT	PCDHB7	406	Q9Y5E2
ADVDTKPAYQNLRQR	BOD1L1	76	Q8NFC6
FVLEPYKLENARLSR	CEP135	66	Q66GS9
PSLYVRKQRALEAEL	APC2	716	O95996
ADARVRTIKLSPTYQ	APC2	986	O95996
QNSYRAKEPILALRR	ATR	1891	Q13535
PAIRAYLKTIRQLDN	IL31	86	Q6EBC2
KREDLVYQSTVRLPE	IGSF21	91	Q96ID5
QRKTQIYSDPLRDLL	DOCK11	51	Q5JSL3
RRTLENLIPDTKYEV	COL12A1	776	Q99715
YSLQRTSPEKNERVR	PRMT7	346	Q9NVM4
LSPALNALKQEEYSR	CCDC81	416	Q6ZN84
NSRTPNKIDLYDVRR	CACNA2D1	226	P54289
LTNFLVRYSPVKNEE	FN1	1386	P02751
DYRIPKIRISTQQAE	DIS3L	371	Q8TF46
RKIVSDYQRDPAITS	CPA4	196	Q9UI42
SLLVRNVNYEIPSLK	CDK5RAP3	116	Q96JB5
STPVQRQLVDIRYSK	CPAMD8	336	Q8IZJ3
RDLYRSLNDPRDSQK	DSP	2156	P15924
LRNLYDSIRNEPFKI	CYTH2	231	Q99418
PKRSRTAYTRQQVLE	HOXC4	156	P09017
NKLISAEVPSYQRLV	HOXD10	121	P28358
PLAQLQSRQRDYKLA	CC2D1A	256	Q6P1N0
SYVPSRAEIKRQAQR	CCDC183	506	Q5T5S1
PYFRNILQSETEKLT	DLGAP5	431	Q15398
TVNPIIYALRSKDLR	CNR1	391	P21554
QPRSYTVQLALRKVS	FBXO24	281	O75426
QTIRQVPNDSDRKYL	LYRM2	31	Q9NU23
DLRTELSKRIAPCYQ	ITGA4	171	P13612
RYDQFLREVLKLPTA	DTNA	166	Q9Y4J8
YEENSQPRRNLTKLS	CBL	141	P22681
IARYSDPIDKRRTSN	CCDC168	2486	Q8NDH2
ITLDRYDISVKPANR	GPR22	136	Q99680
RSLETVYLERNPLQK	PPP1R7	321	Q15435
TSYPTLRIEKNDLRS	RYK	296	P34925
VPYRLLDEATKRSNR	RYR1	1021	P21817
LNTLRYADRVKELSP	KIF2C	576	Q99661
IQYIKVPVTDARDSR	DUSP21	66	Q9H596
TAKLQLQTRRPSYLE	FAM167B	31	Q9BTA0
TRKPEEENSQYLSSR	MAP3K19	356	Q56UN5
LSTAEAKPIIRSYNR	DNAH5	651	Q8TE73
PLTSSERIDKQIRYI	IL6	46	P05231
SESPRDSVVRKQYVQ	FAM126B	396	Q8IXS8
RLKRAEAPTNESYQL	LIFR	381	P42702
SLEQSPLLEDKYRRA	MEF2D	106	Q14814
SQDAQEIIRPRRCKY	MIER1	141	Q8N108
NPLIYTLRNRDVKAA	OR2AT4	291	A6NND4
LLEKRRQITNALYEP	NAP1L6P	86	A6NFF2
RPTANYVSNKDRLVT	OR10R2	281	Q8NGX6
NPLIYTLRNAEVKSA	OR4C6	281	Q8NH72
LEAINRKLISSQPYV	KIF13A	1536	Q9H1H9
IAIKEIPERDSRYSQ	MAP3K5	706	Q99683
PYLIRRIEELNKTAS	MTA3	21	Q9BTC8
ETLTLQKQLRYRFPE	RPUSD1	36	Q9UJJ7
QVINELRNTSYRPKV	RTEL1	121	Q9NZ71
TIKTDRCPLRRQNYD	MRPS35	206	P82673
LETRKSYPDQRSISQ	SKOR1	816	P84550
ELYRRQIATQPRKSN	USH2A	4671	O75445
RELNSTYSEQDPLLK	UTP20	2676	O75691
QLRKLRAAQLEPITY	RHOF	141	Q9HBH0
LTLSQKRPYVDEAER	SOX7	86	Q9BT81
LKPQRYRNEENDSSL	PWWP2A	476	Q96N64
IYEQAKRRRISPADT	TBR1	631	Q16650
TYRELIEQLRNKPSD	STIP1	151	P31948
ATASKPYLQLRVDIR	TBC1D25	111	Q3MII6
SERTLSYAKARQEPE	SPATA21	186	Q7Z572
LRKIEATNNPRLSYI	LRRN3	311	Q9H3W5
AQSARIPSDVKVYNL	LRRN3	566	Q9H3W5
DLQTLRENVRKRLYP	TAF1	1426	P21675
ELDPSNTKALYRRAQ	PPID	301	Q08752
QSVSPRESYRENKRK	PROX1	196	Q92786
RLYIEQKTNLPALNR	GPER1	336	Q99527
EYLPSEQDVLRSRVK	GNAT2	166	P19087
TRLFEKPLDSQSIYQ	SCG2	336	P13521
LLRDSRNYSQETVPK	KIAA1217	1251	Q5T5P2
ELTRIVRNADPIAKY	SLFN11	726	Q7Z7L1
TYSLNKIPERNLETV	TANC2	236	Q9HCD6
EYTSQLLKRREVSVP	WDR17	1186	Q8IZU2
PYLIRRIEELNKTAN	MTA1	21	Q13330
LQKYPVRVTREEQSH	NPRL2	326	Q8WTW4
VSARQKPRANYLEDR	STXBP3	511	O00186
RSAPVYKRIRDVTNN	DIS3	101	Q9Y2L1
PSNYEILVKAARSRN	DIS3	696	Q9Y2L1
RARYKQSLDPTVDEV	RPTOR	116	Q8N122
IARVTFDLYRLNPKD	CIDEA	126	O60543
NRSQYERPNETKIRS	CKAP2L	306	Q8IYA6
YALPESERKLQSSIQ	NCAPG2	131	Q86XI2
PRETSKNILINFYRA	C11orf40	46	Q8WZ69
IKTPYQSAQRAELVA	ERVK-25	486	P63136
YDRISTRPFLNNIEK	PIK3R4	111	Q99570
KYLQDQLSPLTRQRE	TNIP1	396	Q15025
QLSPLTRQREYQEKE	TNIP1	401	Q15025
VTRRPKASDYQRLDQ	TGOLN2	421	O43493
YSLVPDRTVADRQLK	STK19	176	P49842
QKLNRYPASSLVVVR	TMEM59	286	Q9BXS4
LRQRYTAKRQPILDA	STK3	466	Q13188
YQNPRRSFRSLIEEK	ZNF700	76	Q9H0M5
KDQILTDSRYNPRIL	WASHC5	396	Q12768
AYPTDLSTIKQRLEN	PHIP	1201	Q8WWQ0
SRVNRELSKAPYLRQ	REV3L	3111	O60673
IYQTLSPRKISRDEV	STIM2	616	Q9P246
PLESSQVKYLRRELI	TFG	96	Q92734
DKELRPDNRLSQSVY	WASF3	211	Q9UPY6
PYQKALLTLNRISVE	KCNJ16	401	Q9NPI9
EITKSLRRPETSYRQ	TNC	756	P24821
IKTPYQSAQRAELVA	ERVK-8	486	P63133
IKTPYQSAQRAELVA	ERVK-11	486	Q9UQG0
QNKELVSYRAINRPD	SCFD1	166	Q8WVM8
YDKNISPRENILVSL	SCD	276	O00767
RKILLSRINNYTIPE	TTC17	586	Q96AE7
VEKQASRDLEQPTYR	TJP1	1046	Q07157
SLEERRAQLPKYQRN	ZNF207	371	O43670
ESNIEKQIYLPSTRA	ZBED6	116	P86452
SIESLLRENLYPKAN	ZBTB7C	226	A1YPR0
LSPSQKNLYRDVTLE	ZNF101	21	Q8IZC7
INAAYKPSRVLRELQ	SFMBT1	546	Q9UHJ3
YRRNVKRTSPEELLN	SPANXB1	61	Q9NS25
QDSRQKAVRPLELAY	USP18	111	Q9UMW8
EELYSKVTPRRNRQQ	UBASH3B	16	Q8TF42
EDPYSVKRNVARTLN	TUT7	596	Q5VYS8
PNRILSDEKNYATIV	VWA8	1356	A3KMH1
YKERAPEQLRALESS	ZHX3	616	Q9H4I2
ATQKQTESYLRPLFR	PRPF18	221	Q99633
DNPSSLSLVEIYKQR	TRRAP	3586	Q9Y4A5
STRRRQKYQESQEPL	VRK2	396	Q86Y07
KVATELQPSQRRYIS	TNS2	271	Q63HR2
EVRKTSIKIPSNRYN	ZFYVE9	1131	O95405
YLRVRNKSDIAPSQQ	KIAA0586	1446	Q9BVV6
YKRPQELETFSLLSN	ZC3H7B	171	Q9UGR2
LEKQRVSSSVERPYI	ZSCAN23	236	Q3MJ62
TIERNTKPYRKDENS	AGL	781	P35573
YITRPEAEAALRKIN	LCP2	426	Q13094
AIRKNVNIYRDSAIP	NMD3	451	Q96D46
ISRQHSYDNIVDKPR	GRIN2A	1286	Q12879
YNDSPELRRVAQAQK	NEB	221	P20929